Condition category
Respiratory
Date applied
19/08/2011
Date assigned
28/09/2011
Last edited
28/07/2016
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Pneumothorax (collapsed lung) occurs when air leaks into the space between the lungs and chest wall. This buildup of air puts pressure on the lung, so it cannot expand as much as it normally does when you take a breath. In most cases only part of the lung collapses, in which case the patient is monitored with a series of chest X-rays until the air is completely absorbed and the lung has re-expanded. This may require bed rest as any exertion may aggravate the collapse. Supplemental oxygen can speed up the absorption process. If a larger area of the lung has collapsed, it's likely that a needle or chest tube will be used to remove the air. The hollow needle or tube is inserted between the ribs into the air-filled space that is pressing on the collapsed lung. A syringe is attached so the doctor can pull out the excess air - just like a syringe is used to pull blood from a vein. This is called manual aspiration. Chest tubes can also be attached to a suction device (digital drainage device) that continuously removes air from the chest cavity and may be left in place for several hours to several days. The aim of this study is to compare the effectiveness of manual aspiration with a syringe versus a digital drainage device.

Who can participate?
Patients with a pneumothorax

What does the study involve?
Participants are randomly allocated to be treated with either manual aspiration or a digital drainage device. Six hours later participants undergo a chest x-ray to assess the effectiveness of the treatment.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Donostia Hospital (Spain)

When is the study starting and how long is it expected to run for?
September 2011 to September 2014

Who is funding the study?
Hospital Donostia (Spain)

Who is the main contact?
Dr Borja Aguinagalde
borja.aguinagaldevaliente@osakidetza.net

Trial website

Contact information

Type

Scientific

Primary contact

Dr Borja Aguinagalde

ORCID ID

Contact details

Paseo Mons 76
1A
Donostia-San Sebastian
20015
Spain
-
aguinavali@hotmail.com

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

NEI0111

Study information

Scientific title

Manual Aspiration Versus DIgital drainage system in spontaneous primary pneumothorax: open blinded two parallel group randomised controlled trial

Acronym

AMVADI

Study hypothesis

AMVADI Aspiración manual versus aspiración digital (Manual aspirtion versus digital aspiration)

Spontaneous pneumothorax is an extremely frequent pathology. Despite this, there is no clear consensus on managing these patients. Therefore, there are three systematic reviews that compare percutaneous aspiration with tube drainage for treating idiopathic spontaneous pneumothorax. The conclusion of these systematic reviews is that percutaneous aspiration is similar or even better than tube drainage in terms of resolution of the pneumothorax, rates of relaps and hospital admission. We think that aspiration with digital drainage device is even better than manual aspiration for treating primary spontaneous pneumothorax in terms of resolution of the pneumothorax, rates of relaps and hospital admission.

Digital drainage sytem is more effective than manual aspiration in terms of resolution of the pneumothorax, rates of relapse and hospital admission for treating idiopathic spontaneous pneumothorax.

Ethics approval

Clinical Research Ethics Committee [Comité Ético de Investigación Cínica], Gipuzkoa, 20/10/2010, ref: 9/2010

Study design

Single-centre open blinded two parallel group randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised parallel trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Spontaneous primary pneumothorax

Intervention

Control arm:
A plastic catheter (Pleurocaht 8Fr) is inserted into the second anterior intercostal space on the midclavicular line. The air is pulled out with manual syringe (50cc, until 3500cc or until the excess of air ends).Thereafter, the catheter is closed and a chest X ray performed six hours later (accepted range 4-12h to ensure the patient's sleep). If lung expansion is complete, or if only a small rim of apical pneumothorax is present, the patient is discharged. If no lung expansion or only partial expansion is or a continuous air leak is observed the patient is connected to a water seal aspiration device and proceed to hospital admission.

Intervention arm:
A plastic catheter (Pleurocaht 8Fr) is inserted into the second anterior intercostal space on the midclavicular line. The catheter is connected to a digital aspiration device (Thopaz), regulated to generate a negative pressure of 10 cmH2O. Aspiration is performed until cessation of air occurred or for a maximum of 30 mins. Thereafter, the catheter is closed and a chest X ray performed six hours later (accepted range 4 - 12hours to ensure the patient's sleep). If lung expansion is complete, or if only a small rim of apical pneumothorax is present, the patient is discharged. If no lung expansion or only partial expansion is or a continuous air leak is observed the patient is connected to a water seal aspiration device and proceed to hospital admission.

Intervention type

Procedure/Surgery

Phase

Drug names

Primary outcome measures

Pneumothorax resolution in chest X ray performed six hours after the catheter insertion, accepted range 4-12h to ensure the patient's sleep

Secondary outcome measures

1. Risk of hospital admission
2. Relapse of pneumothorax
3. Resolution after 1 week
4. Percentage of patients that need surgery
5. Percentage of smoking cessation

Overall trial start date

01/09/2011

Overall trial end date

01/09/2014

Reason abandoned

Eligibility

Participant inclusion criteria

Patients with first episode of primary spontaneous pneumothorax

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

104 patients (52 in each of the arms)

Participant exclusion criteria

1. Traumatic or iatrogenic pneumothorax
2. Secondary pneumothorax
3. Catamenial pneumothorax
4. Previous epidodes of oneumothorax
5. Bialteral pneumothorax
6. Tension pneumothorax
7. Immunosuppresion

Recruitment start date

01/09/2011

Recruitment end date

01/09/2014

Locations

Countries of recruitment

Spain

Trial participating centre

Paseo Mons 76, 1A
Donostia-San Sebastian
20015
Spain

Sponsor information

Organisation

Hospital Donostia (Spain)

Sponsor details

Paseo Beguiristain 115
Donostia-san Sebastian
20014
Spain
-
borja.aguinagaldevaliente@osakidetza.net

Sponsor type

Hospital/treatment centre

Website

http://www.hospitaldonostia.org/

Funders

Funder type

Hospital/treatment centre

Funder name

Hospital Donostia (Spain)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes

28/07/2016: Plain English summary added.